LifeVantage appoints new Chief Information and Innovation Officer
Corporation (NASDAQ:LFVN), a company specializing in nutrigenomics, announced the appointment of Todd Thompson as its new Chief Information and Innovation Officer. The company, which has demonstrated ...
LifeVantage Welcomes Todd Thompson as Chief Information and Innovation Officer
We are thrilled to welcome Todd to the LifeVantage team,” said Steve Fife, President and CEO of LifeVantage. “Todd’s exceptional track record in technology leadership and his forward-thinking approach ...
Hosted on MSN1d
Craig-Hallum Initiates Coverage of LifeVantage (LFVN) with Buy Recommendation
Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy ...
LifeVantage announces results of third-party cell study of health weight stack
LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer ...
LifeVantage Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack*
LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...
LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - Buy
LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...
LifeVantage soars after seeing a sales boost from its GLP-1 product
"Second quarter revenue results were exceptional, reflecting strong sales of the MindBody GLP-1 System we launched in October in the United States along with outstanding execution by our team to ...